Cormorant Shows More AMAM Love

JC Parets
April 21, 2023

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.

Cormorant revealed an additional purchase of $58 million in Ambrx Biopharma $AMAM.

Director John Donovan revealed an acquisition of 506 shares of Lockheed Martin Corporation $LMT.

Here’s The Hot List, with data through April 20, 2023:

In another Form 4, the CEO and president of ServisFirst Bancshares $SBFS reported a purchase of approximately 3,000 shares, equivalent to $149,853.

In the options market, there was bullish flow in Walgreens Boots Alliance $WBA, The Gap $GPS, Verona Pharma plc $VRNA, and SunPower Corporation $SPWR.

Have a great weekend. We'll be back on Monday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under: